Nav: Home

Pharmacogenetics experts establish common vocabulary in bid to advance precision medicine

July 21, 2016

Experts led by St. Jude Children's Research Hospital have tackled a language barrier that is an obstacle to using precision medicine to enhance medication safety and effectiveness - the lack of standard pharmacogenetic terminology. The results appear today in the journal Genetics in Medicine.

Pharmacogenetics is the study of how genetics, particularly genetic variations in single genes, influences how individuals respond to drugs, including their risk for serious side effects or likely benefit. Now a national panel of pharmacogenetics experts from clinical laboratories, research and patient care has sifted through dozens of terms and reached a consensus on a vocabulary for reporting clinical pharmacogenetic test results.

"We hope that establishing standard terminology will encourage more widespread inclusion of pharmacogenetic results in the electronic health records of patients to help realize the promise of precision medicine to individualize patient care," said first and corresponding author Kelly Caudle, Pharm.D., Ph.D., of the St. Jude Department of Pharmaceutical Sciences. She is coordinator of the Clinical Pharmacogenetics Implementation Consortium (CPIC®), the National Institutes of Health (NIH) supported group that spearheaded the project and is led by investigators from St. Jude and Stanford University.

The gene TPMT is an example of how words matter in pharmacogenetics. The gene encodes instructions for an enzyme that helps break down chemotherapy agents called thiopurines. Differences in the DNA that make up TPMT mean a small percentage of individuals do not make a functional enzyme. At standard doses, they are at high risk for serious side effects from the drugs.

Caudle and her colleagues identified 14 terms that medical testing laboratories, researchers and others use to describe the high-risk TPMT variations. The terms included "deficient function," "no activity," "homozygous deficient" and "absent activity." Using an established consensus-building method that included multiple rounds of surveying, more than 90 percent of participating experts agreed to replace those descriptions with a single term, "poor metabolizer."

Participants reached consensus on one set of terms to describe how gene variations affected function and other standardized terminology to describe how the variations likely impact clinical care, including drug metabolism and transport.

"Inconsistent terms can be confusing to clinicians, laboratory staff and patients," said senior author James Hoffman, Pharm.D., an associate member of the St. Jude Pharmaceutical Sciences department. "The lack of standard vocabulary has been a major obstacle to incorporating pharmacogenetic results in the patients' electronic health record to help guide prescribing."

The standardized pharmacological terms included in this report have been endorsed by the Association for Molecular Pathology, whose membership includes more than 2,000 laboratory medicine professionals worldwide. The recommendations will be distributed to pharmacogenetic testing laboratories, professional organizations and others, including dozens of institutions and commercial clinical laboratories worldwide that belong to CPIC, the project's sponsor.

Terminology will be revised and expanded as additional information becomes available and the specialty grows, Caudle said.
St. Jude has used pharmacogenetics for more than 20 years to help guide thiopurine dosing in pediatric leukemia patients. The effort was expanded five years ago to include many other drugs and diseases through the PG4KDS protocol. Since CPIC was established in 2009, the organization has developed 17 clinical guidelines designed to help guide the use of pharmacogenetic findings into patient care.

The other authors are Henry Dunnenberger, NorthShore University HealthSystem, Evanston, Ill.; Robert Freimuth, Mayo Clinic, Rochester, Minn.; Josh Peterson, Vanderbilt University Medical Center, Nashville; Jonathan Burlison and Mary Relling, both of St. Jude; Michelle Whirl-Carrillo and Teri Klein, both of Stanford University, Stanford, Calif.; Stuart Scott, Icahn School of Medicine at Mount Sinai, New York; Heidi Rehm, Harvard Medical School, Cambridge, Mass.; and Marc Williams, Geisinger Health System, Danville, Penn.

The study was funded in part by grants (GM115264, GM61374, GM104401, GM61388) from the National Institutes of Health, and ALSAC.

St. Jude Children's Research Hospital

Related Genetics Articles:

Mapping millet genetics
New DNA sequences will aid in the development of improved millet varieties
Genetics to feed the world
A study, published in Nature Genetics, demonstrated the effectiveness of the technology known as genomic selection in a wheat improvement program.
Genetics researchers find new neurodevelopmental syndrome
Researchers have identified a gene mutation that causes developmental delay, intellectual disability, behavioral abnormalities and musculoskeletal problems in children.
The genetics of cancer
A research team has identified a new circular RNA (ribonucleic acid) that increases tumor activity in soft tissue and connective tissue tumors.
New results on fungal genetics
An international team of researchers has found unusual genetic features in fungi of the order Trichosporonales.
Mouse genetics influences the microbiome more than environment
Genetics has a greater impact on the microbiome than maternal birth environment, at least in mice, according to a study published this week in Applied and Environmental Microbiology.
New insights into genetics of fly longevity
Alexey Moskalev, Ph.D., Head of the Laboratory of Molecular Radiobiology and Gerontology Institute of Biology, and co-authors from the Institute of biology of Komi Science Center of RAS, Engelgard's Institute of molecular biology, involved in the study of the aging mechanisms and longevity of model animals announce the publication of a scientific article titled: 'The Neuronal Overexpression of Gclc in Drosophila melanogaster Induces Life Extension With Longevity-Associated Transcriptomic Changes in the Thorax' in Frontiers in Genetics - a leading open science platform.
Some personal beliefs and morals may stem from genetics
Penn State researchers found that while parents can help encourage their children to develop into responsible, conscientious adults, there is an underlying genetic factor that influences these traits, as well.
X chromosome: how genetics becomes egalitarian
In cell biology, men and women are unequal: men have an X chromosome, while women have two.
The link between obesity, the brain, and genetics
Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.
More Genetics News and Genetics Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#540 Specialize? Or Generalize?
Ever been called a "jack of all trades, master of none"? The world loves to elevate specialists, people who drill deep into a single topic. Those people are great. But there's a place for generalists too, argues David Epstein. Jacks of all trades are often more successful than specialists. And he's got science to back it up. We talk with Epstein about his latest book, "Range: Why Generalists Triumph in a Specialized World".
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at